À PROPOS DE CET ÉPISODE

Anglais
États-Unis

MONTRER LES NOTES 🔗

TRANSCRIPTION 🔗

RECHERCHER LES ÉPISODES PASSÉS

Rechercher les épisodes précédents de Biohacking Autism with Nadia Elkhatib..

AUTRES ÉPISODES DANS CE PODCAST

More than 600 companies are building autism technology, yet most families have never heard of them. This 20-MIN ESSENTIALS edition condenses my conversation with Dan Feshbach, founder of Multiple and co-founder of TeachTown, into the core ideas families need most. Dan and I explore AI for autism,…
A shorter, focused edition of our full John Slattery conversation. Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism an…
More than 600 companies are building autism technology, yet most families have never heard of them. What could change if AI, communication tools, sensory technology, and future neurotechnology reached the people who need them? Dan Feshbach, founder of Multiple and co-founder of TeachTown, joins Na…
What does the brain need to build itself, and why does the answer matter for a child with autism and for the aging brain? In this episode of Biohacking Autism, Nadia Elkhatib talks with Dr. Dayan Goodenowe, PhD, neuroscientist, biochemist and founder of Prodrome Sciences, about autism brain develop…
Avertissement: Le podcast et les illustrations intégrés sur cette page proviennent de Nadia Elkhatib, qui est la propriété de son propriétaire et n'est ni affilié ni approuvé par Listen Notes, Inc.